as 10-24-2025 3:52pm EST
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 2.8B | IPO Year: | 2015 |
| Target Price: | $31.14 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.87 - $31.98 | Next Earning Date: | 11-11-2025 |
| Revenue: | $3,237,000,000 | Revenue Growth: | 12.05% |
| Revenue Growth (this year): | 9.85% | Revenue Growth (next year): | 9.47% |
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bane Harrison R. | SGRY | National Group President | Sep 4 '25 | Sell | $22.48 | 9,339 | $209,940.72 | 120,794 | |
| DeLuca Teresa | SGRY | N/A | Aug 11 '25 | Sell | $22.74 | 20,018 | $455,209.32 | 45,173 | |
| Maryland Patricia Anne | SGRY | N/A | Aug 11 '25 | Sell | $22.74 | 20,018 | $455,209.32 | 4,565 |
SGRY Breaking Stock News: Dive into SGRY Ticker-Specific Updates for Smart Investing
StockStory
21 days ago
StockStory
a month ago
Simply Wall St.
a month ago
StockStory
2 months ago
Barrons.com
4 months ago
GlobeNewswire
4 months ago
Simply Wall St.
4 months ago
StockStory
5 months ago
The information presented on this page, "SGRY Surgery Partners Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.